MedPath

Evaluation the effect of intraoperative administration of magnesium sulfate on post operative pain of patients undergoing general anesthesia for inguinal hernioraphy

Phase 2
Conditions
Postoperative Pain.
Acute pain
Registration Number
IRCT2012102811294N1
Lead Sponsor
Vice chancellor for research of Ahvaz Jondishapour University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

patients with ASA 1 or 2 ; the patients without history of drug abuse ; without sensitivity to magnesium , opioids and analgesics ; any hepatic, renal, cardiovascular, neuromascular or neurological disorder ; not to use calcium channel blockers
Exclusion criteria: patients with preoperative hemodynamic instability ; preoperative respiratory distress; preoperative nausea and vomiting or any important adverse effects ; patients with magnesium infusion time less than one hour and more than 3 hours.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain score. Timepoint: 30 min , 2 hours, 6 hours, 12 hours, 24 hours after surgery. Method of measurement: Visual analogue scale.
Secondary Outcome Measures
NameTimeMethod
Meperidine consumption. Timepoint: in 24 hours after surgery. Method of measurement: milligramms.;Incidence of adverse effects. Timepoint: In 24 hours after surgery. Method of measurement: Asking from patients.
© Copyright 2025. All Rights Reserved by MedPath